![Neil Klompas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Klompas
Direktor/Vorstandsmitglied bei
NERVGEN PHARMA CORP.
Vermögen: - $ am 31.05.2026
Profil
Neil A. Klompas is President & Chief Executive Officer at Augurex Life Sciences Corp.
since 2024.
Mr. Klompas is Director at HTuO Biosciences, Inc., Canadian Gene Cure Foundation, and The Chartered Professional Accountants of British Columbia.
Mr. Klompas is Independent Non-Executive Director at NervGen Pharma Corp.
since 2024.
Mr. Klompas is Director at InMed Pharmaceuticals, Inc. starting 2025.
Formerly, Mr. Klompas was Chairman at Ovensa, Inc. and Independent Director at Liminal BioSciences, Inc. Mr. Klompas was Chief Operating Officer at Zymeworks BC, Inc. in 2022.
Mr. Klompas was Manager-Mergers & Acquisitions Transactions at KPMG LLP from 2005 to 2007.
Mr. Klompas was Audit Manager at KPMG LLP (Canada) from 2000 to 2005.
Mr. Klompas was President & Chief Operating Officer at Zymeworks, Inc. from 2022 to 2023.
Mr. Klompas completed undergraduate studies at the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 16.05.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| 19.12.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Neil Klompas
| Unternehmen | Position | Beginn |
|---|---|---|
| NERVGEN PHARMA CORP. | Direktor/Vorstandsmitglied | 22.07.2024 |
| INMED PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 09.10.2025 |
The Chartered Professional Accountants of British Columbia
 The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association of accountants | Corporate Officer/Principal | - |
Canadian Gene Cure Foundation
 Canadian Gene Cure Foundation The Canadian Gene Cure Foundation is a company based in Victoria, Canada. | Direktor/Vorstandsmitglied | - |
Augurex Life Sciences Corp.
 Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Develops biomarkers that transform patient clinical management | Vorstandsvorsitzender | 06.08.2024 |
HTuO Biosciences, Inc.
 HTuO Biosciences, Inc. BiotechnologyHealth Technology Operates as a bioscience company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Neil Klompas
| Unternehmen | Position | Ende |
|---|---|---|
| ZYMEWORKS INC. | Präsident | 30.06.2023 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Finanzdirektor/CFO | 24.02.2022 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01.01.2007 |
| ░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Neil Klompas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
InMed Pharmaceuticals, Inc.
 InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG LLP (Canada)
 KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Commercial Services |
Augurex Life Sciences Corp.
Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Develops biomarkers that transform patient clinical management | Health Technology |
The Chartered Professional Accountants of British Columbia
The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association of accountants | Commercial Services |
Ovensa, Inc.
 Ovensa, Inc. Internet Software/ServicesTechnology Services Provides nano medicine delivery technology platforms to solve pharmacokinetic challenges | Technology Services |
Canadian Gene Cure Foundation
Canadian Gene Cure Foundation The Canadian Gene Cure Foundation is a company based in Victoria, Canada. | |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
HTuO Biosciences, Inc.
HTuO Biosciences, Inc. BiotechnologyHealth Technology Operates as a bioscience company | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Wählen Sie MarketScreener 
